Xiao Yao Wan
Shop NowOverview
What is Xiao Yao Wan?
Xiao Yao Wan is an 8-herb classic Chinese herbal medicine widely used in China to support menstrual health, regulate menstrual irregularities, and relieve symptoms associated with liver qi stagnation and blood deficiency in traditional Chinese medicine.
Product Information
| Chinese name | 逍遥丸 |
|---|---|
| Pinyin | Xiao Yao Wan |
| Brand | Jiuzhitang |
| China Drug Approval No. | Z43020469 |
| Dosage form | pill |
| Traditional function | Soothes the liver, strengthens the spleen, nourishes the blood, and regulates menstruation. |
| Strength | Each 8 pills are equivalent to 3 g of original medicinal materials. |
| Recommended use | The labeled traditional use concerns liver qi constraint with spleen weakness and associated menstrual or digestive symptoms; it is not proof of effectiveness for every cause of these symptoms. |
| GTIN | 6924332730173 |
Evidence at a Glance
Small direct trials and formula-level reviews report possible benefits in selected depression, functional-dyspepsia, and anxiety settings. The evidence varies in population, preparation, comparator, and study quality and does not establish this exact commercial product for those conditions.
Consult a physician before use during pregnancy. Seek medical advice for abnormal bleeding, marked menstrual changes, or symptoms that do not improve after two weeks.
Uses
Common Uses
Xiao Yao Wan is traditionally used
- Support menstrual health
- Help regulate menstrual irregularities
- Relieve symptoms associated with stress
- Mood imbalance
- Discomfort related to the menstrual cycle
Traditional & Labeled Uses
疏肝健脾,养血调经
Soothes the liver, strengthens the spleen, nourishes the blood, and regulates menstruation.
- Menstrual irregularity associated with the labeled traditional pattern
- Chest or flank distension and pain
- Dizziness
- Reduced appetite
Labeled traditional use is distinct from proof of clinical effectiveness for a diagnosed condition. New, severe, persistent, or unexplained symptoms require appropriate medical assessment.
Understanding the TCM Perspective
The label describes a Traditional Chinese Medicine pattern often translated as liver qi constraint with spleen weakness.
This Learn information is for educational purposes only. Always consult a healthcare provider before starting TCM treatments.
Safety
Pregnancy
Consult a physician before use during pregnancy.
Allergy
Stop use and seek advice if an allergic reaction occurs. People with an allergy-prone constitution should use caution.
Drug Interactions
Interactions may occur when used with other medicines. Consult a physician or pharmacist before combining products.
When to Seek Medical Advice
Seek care for sudden reduction or delay of previously regular menstruation, irregular vaginal bleeding, unusually heavy bleeding, severe symptoms, or no improvement after two weeks. Consult a clinician before long-term use.
Contraindications
- Do not use if you are allergic to this product or any listed ingredient.
- Do not use during a cold unless a clinician advises otherwise.
- The instructions state that this product is unsuitable for people with excessive menstrual bleeding.
Reported Adverse Reactions
- The accessible instructions do not clearly establish a complete adverse-reaction profile; absence of listed reactions is not proof of no risk.
Evidence
Human Clinical Evidence
Xiaoyao Pills, a Chinese patent medicine, treats mild and moderate depression: A randomized clinical trial combined with DNA methylation analysis
The authors reported improvement concentrated in participants younger than 45 years with mild or moderate depression.
Xiaoyao pill for treatment of functional dyspepsia in perimenopausal women with depression
The trial reported improvements in depression scores and selected gastric-function measures relative to placebo.
Safety and efficacy of Xiaoyao-san for the treatment of functional dyspepsia: A systematic review and meta-analysis
The review reported pooled improvement in total clinical effectiveness and dyspepsia symptom scores in several comparisons.
Efficacy and safety of Xiaoyao San for the treatment of anxiety: A systematic review and meta-analysis with trial sequential analysis
The review reported pooled improvements for several anxiety outcomes, including add-on comparisons.
Verification
PRODUCT IDENTITY
- Brand Name
- Jiuzhitang
- Chinese Name
- 九芝堂
- Manufacturer
- Jiuzhitang Co., Ltd.
- China drug approval number
- Z43020469
These are Chinese product-registration details. They do not establish approval or availability in another country.
Verified by the AuthHerb Verification Team
- Brand relationship confirmed
- Manufacturer legal name confirmed
- Approval number confirmed
- Current packaging matched
- Registration holder / manufacturer checked
- Authenticity method checked
- Label/source evidence recorded
Ingredients
The linked Xiao Yao Wan formula lists 8 ingredients. The first six ingredients are shown below.
- Bupleurum root — 柴胡
- Chinese angelica root — 当归
- White peony root — 白芍
- Stir-fried Atractylodes rhizome — 炒白术
- Poria — 茯苓
- Prepared licorice root — 炙甘草
Official Label Dosage
Take 8 pills orally three times daily.
Follow the current package insert if its instructions differ.
Missed Dose Information
No product-specific missed-dose instruction was identified.
Additional Directions
Follow the product label. Consult a physician before long-term use.
If symptoms do not improve after two weeks, seek medical advice.
A purchase option’s quantity does not define how long you should take the medicine.
Frequently Asked Questions About Xiao Yao Wan
Its label describes use for menstrual irregularity, chest or flank discomfort, dizziness, and reduced appetite associated with a traditional pattern of liver qi constraint and spleen weakness.
No. It is a Traditional Chinese Medicine description and should not replace evaluation for medical causes of menstrual, digestive, mood, or pain symptoms.
The accessible instructions state 8 pills by mouth three times daily. Follow the current physical package insert if it differs.
Consult a physician before use during pregnancy.
Seek care for sudden menstrual changes, irregular or unusually heavy bleeding, severe symptoms, or no improvement after two weeks.
No. Limited trials and formula-level reviews report possible benefits in selected settings, but they do not establish effectiveness of approval number Z43020469 for those conditions.
References
-
[1]Xiaoyao Pills, a Chinese patent medicine, treats mild and moderate depression: A randomized clinical trial combined with DNA methylation analysis
Population: 41 adults with depression
Indication: Depression
Intervention: Xiaoyao Pills, 8 pills three times daily
Comparison: Placebo
Sample size: 41
Duration: 8 weeks intended treatment
Reported findings
The authors reported improvement concentrated in participants younger than 45 years with mild or moderate depression.
Interpretation
This is small direct finished-formula evidence and does not establish benefit for major depressive disorder or for this exact approval-number product.
Limitations
Under-recruited trial with subgroup-dependent findings; only 41 participants were randomized.
Xiaoyao Pills, a Chinese patent medicine, treats mild and moderate depression: A randomized clinical trial combined with DNA methylation analysis. 2024. https://doi.org/10.1016/j.phymed.2024.155660
Study type: Double-blind randomized placebo-controlled trial
PMID: 38815407
-
[2]Xiaoyao pill for treatment of functional dyspepsia in perimenopausal women with depression
Population: 180 perimenopausal women with functional dyspepsia and depression
Indication: Functional dyspepsia with depression
Intervention: Xiaoyao pill
Comparison: Placebo
Sample size: 180
Duration: 8 weeks with 6-month follow-up
Reported findings
The trial reported improvements in depression scores and selected gastric-function measures relative to placebo.
Interpretation
The result is limited to a specific population and does not verify the exact commercial product in this build.
Limitations
Single-population, single-study evidence with uncertain generalizability.
Xiaoyao pill for treatment of functional dyspepsia in perimenopausal women with depression. 2014. https://doi.org/10.3748/wjg.v20.i44.16739
Study type: Double-blind randomized placebo-controlled trial
PMID: 25469046
-
[3]Safety and efficacy of Xiaoyao-san for the treatment of functional dyspepsia: A systematic review and meta-analysis
Population: 707 participants across 6 randomized trials
Indication: Functional dyspepsia
Intervention: Xiaoyao-san across included trials
Comparison: Western medicine comparators
Sample size: 707
Duration: Varied across included trials
Reported findings
The review reported pooled improvement in total clinical effectiveness and dyspepsia symptom scores in several comparisons.
Interpretation
This is formula-level review context, not proof for approval number Z43020469.
Limitations
Certainty ranged from very low to high; preparations and methods varied and heterogeneity was present.
Safety and efficacy of Xiaoyao-san for the treatment of functional dyspepsia: A systematic review and meta-analysis. 2023. https://doi.org/10.3389/fphar.2023.1114222
PMID: 37124216
-
[4]Efficacy and safety of Xiaoyao San for the treatment of anxiety: A systematic review and meta-analysis with trial sequential analysis
Population: 1,256 participants across 14 trials
Indication: Anxiety
Intervention: Xiaoyao San alone or added to anxiolytic treatment
Comparison: Anxiolytic treatment or control regimens
Sample size: 1256
Duration: Varied across included trials
Reported findings
The review reported pooled improvements for several anxiety outcomes, including add-on comparisons.
Interpretation
The findings are formula-level and do not establish effectiveness of this exact commercial product.
Limitations
Most trials had moderate or high risk of bias; interventions and comparators varied.
Efficacy and safety of Xiaoyao San for the treatment of anxiety: A systematic review and meta-analysis with trial sequential analysis. 2023. https://doi.org/10.3389/fphar.2023.1169292
Study type: Systematic review, meta-analysis, and trial sequential analysis
PMID: 37905203